跳至主要内容
临床试验/ISRCTN13242733
ISRCTN13242733进行中(未招募)未知

The Troponin-only Manchester Acute Coronary Syndromes (T-MACS) Choice feasibility study

niversity of Manchester0 个研究点目标入组 800 人开始时间: 2021年10月19日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
800

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Adult patients aged 18 years or above
  • 2. Presenting to the ED with:
  • 2.1. Pain, discomfort, or pressure in the chest, epigastrium, neck, jaw, or upper limbs
  • 2.2. No obvious non-cardiac source
  • 2.3. Symptoms the treating emergency physicians feel warrant investigation for suspected ACS

排除标准

  • 1. Patients with peak symptoms >12 hours before presenting to the ED
  • 2. Patients requiring referral for immediate primary percutaneous coronary intervention due to unequivocal evidence of ST elevation myocardial infarction
  • 3. Patients requiring hospital admissions for another medical condition
  • 4. Patients that lack mental capacity to provide written informed consent
  • 5. Patients whose level of English does not allow them to participate in the SDM conversation in a meaningful way.

研究者

发起方
niversity of Manchester

相似试验

Shared decision-making in the emergency department... | 临床试验